Six months after launch, a startup founded by three leaders in the blood testing field is being acquired by medical testing giant Quest Diagnostics. Quest announced on Thursday that it is buying ...

Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of drug called a T cell engager. These drugs bind to a cancer cell and a T cell simultaneously, ...

A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of lauded cancer researcher Bert Vogelstein’s lab. The Boston-based company, ...

President Bush's recent decision to allow federal funding of limited research using embryonic stem cells followed weeks of heated debate among scientists, policymakers, medical experts, and patient ...